Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

MDGL - Madrigal Pharmaceuticals, Inc.... | Finranks

Home

/

MDGL

M

Madrigal Pharmaceuticals, Inc. (MDGL)

NMS – Real Time Price. Currency in USD

540.94

+5.67 (1.06%)

Market open: Aug 12, 2026, 11:29 AM EDT

534.99

-0.28 (-0.05%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

958M

180M

0

0

Cost of goods sold

-58M

-7M

-527K

-467K

Gross Profit

901M

173M

-527K

-467K

Operating expenses (excl. COGS)

-1.20B

-671M

-380M

-293M

Operating Income

-300M

-498M

-380M

-294M

Non-operating income, total

12M

32M

7M

-2M

Pretax income

-288M

-466M

-374M

-295M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-288M

-466M

-374M

-295M

Discontinued operations

0

0

0

0

Net income

-288M

-466M

-374M

-295M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

1.26B+20.9%

1.04B+62.7%

641M+76.7%

363M

Total current assets

1.25B

1.03B

637M

361M

Total non-current assets

14M

9M

3M

1M

Total liabilities

657M+128.2%

288M+22.4%

235M+42.4%

165M

Total current liabilities

310M

169M

119M

116M

Total non-current liabilities

347M

119M

117M

49M

Total equity

603M

754M

405M

197M

Total liabilities & shareholders' equities

1.26B

1.04B

641M

363M

Total debt

348M+190.7%

120M+2.0%

117M+134.9%

50M

Name

2025

2024

2023

2022

Cash from operating activities

-190M

-456M

-324M

-225M

Cash from investing activities

32M

-274M

-503M

207M

Cash from financing activities

256M

735M

595M

313M

Free cash flow

-190M+58.4%

-457M-40.3%

-326M-44.7%

-225M